IRLAB to Present at Pareto Securities’ 13th Annual Healthcare Conference
[ad_1] GOTHENBURG, SE / ACCESSWIRE / September 07, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 7, 2022 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical…